Caricamento...
Interleukin‐22 in urinary tract disease – new experimental directions
Interleukin (IL)‐22 is expressed by immune cells in the urinary tract and IL‐22 receptor is expressed in urothelium and renal tubule cells. IL‐22 can be specifically targeted in the urinary tract or conditionally depleted in mice and targeted therapeutically in humans.[Image: see text]
Salvato in:
| Pubblicato in: | Clin Transl Immunology |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7276185/ https://ncbi.nlm.nih.gov/pubmed/32523694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1143 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|